News & Updates

Show Multimedia Only
COVID-linked MIS-C outcomes reassuring at 6 months

COVID-linked MIS-C outcomes reassuring at 6 months

31 Jan 2025 byElvira Manzano

Children and young adults with multisystem inflammatory syndrome in children (MIS-C) related to COVID-19 infection show good cardiovascular and noncardiovascular outcomes at 6 months, according to data from the long-term MUSIC study.

31 Jan 2025
Recurrence scores from 21-gene assay help inform benefits of adjuvant anthracyclines in EBC

Recurrence scores from 21-gene assay help inform benefits of adjuvant anthracyclines in EBC

26 Jan 2025 byMike Ng

The recurrence score derived from a 21-gene expression assay may indicate which patients with early-stage HR+ breast cancer can maintain freedom from distant recurrence for longer with the inclusion of an anthracycline in adjuvant chemotherapy, suggests a post hoc analysis of the TAILORx trial presented at SABCS 2024

26 Jan 2025